Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 May 2010

de Muga Silvia, Hernández Silvia, Agell Laia, Salido Marta, Juanpere Nuria, Lorenzo Marta, Lorente José A, Serrano Sergio, Lloreta Josep

Abstract excerpt

Prostate cancer is the second cause of cancer-related death in men of the Western world. The potential prognostic role of the combined alterations in EGFR and PTEN in prostate cancer is not well established. It was the aim of the study to investigate this role. Prevalence of EGFR and PTEN somatic...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to ErbB Receptors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to In Situ Hybridization, Fluorescence

Share to Neoplasm Staging

Share to Prostatic Neoplasms

Share to PTEN Phosphohydrolase

Share to Severity of Illness Index

Source

Identifiers

PMID: 20208477
DOI: 10.1038/modpathol.2010.45

Genes

EGFR
PTEN

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-20208477-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Molecular alterations of EGFR and PTEN in prostate cancer: association with high-grade and advanced-stage carcinomas.PMID 20208477Read ↗

Molecular Characterization of KRAS, BRAF, and EGFR Genes in Cases with Prostatic Adenocarcinoma; Reporting Bioinformatics Description and Recurrent Mutations.Semantic proximity Read ↗

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.Semantic proximity Read ↗

Cooperation between FGF8b overexpression and PTEN deficiency in prostate tumorigenesis.Semantic proximity Read ↗

Role of PTEN gene in progression of prostate cancer.Semantic proximity Read ↗

Clinical implications of PTEN loss in prostate cancer.Semantic proximity Read ↗

PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade.Semantic proximity Read ↗

[Mutations of oncogenes and tumor suppressor genes in prostate neoplasms].Semantic proximity Read ↗

PTEN Protein Loss by Immunostaining: Analytic Validation and Prognostic Indicator for a High Risk Surgical Cohort of Prostate Cancer PatientsSemantic proximity Read ↗

BRAF and KRAS mutations in prostatic adenocarcinoma.Semantic proximity Read ↗

Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate CancerSemantic proximity Read ↗

Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.Semantic proximity Read ↗

Epidermal Growth Factor Receptor (EGFR) mutation analysis, gene expression profiling and EGFR protein expression in primary prostate cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.